Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups
Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272)
05/2003
05/08/2003US20030088102 Novel process for producing fused imidazopyridine derivatives and novel crystal form
05/08/2003US20030088097 E.g., tert-butyloxycarbonyl-protected 2-(2,2,2-trifluoroethyl)hexahydroimidazo(1,5-a)pyrazine
05/08/2003US20030088096 Preparation by cleavage of triazolopyrimidines or by cyanoamination of sulfonylpyrimidines
05/08/2003US20030088092 Water-soluble porphyrin derivatives and methods of their preparation
05/08/2003US20030087947 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photodynamic therapy
05/08/2003US20030087899 Administering a stress-activated protein kinase inhibitor, particularly a fused pyrrolocarbazole compound.
05/08/2003US20030087895 Fused imidazole derivatives as multidrug resistance modulators
05/08/2003US20030087892 Condensed azepines as vasopressin agonists
05/08/2003US20030087888 Anticancer agents
05/08/2003US20030087881 Quinazoline derivatives used to treat cancer, restenosis, atherosclerosis, endometriosis, and psoriasis
05/08/2003US20030087306 Methods for identifying novel multimeric agents that modulate receptors
05/08/2003CA2466824A1 Pde9 inhibitors for treating cardiovascular disorders
05/08/2003CA2465632A1 Treatment of insulin resistance syndrome and type 2 diabetes with pde9 inhibitors
05/08/2003CA2465497A1 Bridged bicyclic amino acid-derived (1,4) benzodiazepine vasopressin receptor antagonists
05/08/2003CA2464934A1 Pyrimido [4,5-b] indole derivatives
05/08/2003CA2464194A1 N-azabicyclo-substituted hetero-bicyclic carboxamides as nachr agonists
05/07/2003EP1308481A2 Metal-mediated cross-coupling with ring-metalated porphyrins
05/07/2003EP1308439A1 Proline derivatives and use thereof as drugs
05/07/2003EP1307460A1 Method for the production of imidazo-(1,2-c)(2,3)-benzodiazepines and intermediates in the production thereof
05/07/2003EP1307458A1 Pyrrolotriazolopyrimidinone derivatives
05/07/2003EP1307457A1 Azabicyclic compounds, preparation thereof and use as medicines, in particular as antibacterial agents
05/07/2003EP1307456A1 Imidazo-pyrazine derivatives as ligands for gaba receptors
05/07/2003EP1307455A2 Inhibitors of alpha-l beta-2 mediated cell adhesion
05/07/2003EP1307200A2 Substituted-triazolopyrimidines as anticancer agents
05/07/2003EP1147110B1 Pyrazino(aza)indole derivatives
05/07/2003EP1090004B1 A substituted triazolo-pyridazine derivative, pharmaceutical compositions made therefrom
05/07/2003EP1001956B1 2,3-benzodiazepine derivatives
05/07/2003EP0975635B1 Fungicidal trifluoromethylalkylamino-triazolopyrimidines
05/07/2003EP0938491B1 Heterocyclic metallocenes and polymerization catalysts
05/07/2003EP0889863B1 Surface modified carbonate materials
05/07/2003EP0719272B1 Pyrimidine derivatives for labeled binding partners
05/07/2003EP0709386B1 Fused benzazepine derivative and pharmaceutical composition containing the same
05/06/2003US6559374 Multilayer solar cells
05/06/2003US6559319 Synthesis of compounds useful in the manufacture of ketorolac
05/06/2003US6559304 Method for synthesizing caspase inhibitors
05/06/2003US6559174 For therapy of AIDS-related dementia, allergic conjunctivitis, allergic rhinitis, Alzheimer's disease, asthma, atherosclerosis, autologous bone marrow transplantation, certain types of toxic and immune-based nephritis
05/06/2003US6559152 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
05/06/2003US6559151 6-(2-trifluoromethyl-phenyl)-triazolopyrimidines
05/06/2003US6559150 Growth hormone secretagogues
05/06/2003US6559101 Controlling weeds; agriculture
05/06/2003US6558818 Light-emitting dendrimers and devices
05/06/2003US6558696 Desoxypeganine
05/06/2003US6558435 Reactive crystallization method to improve particle size
05/06/2003CA2189698C Substituted 1,2,3-triazol-3-ones
05/02/2003EP1306380A1 Novel expanded porphyrins and process for the synthesis thereof
05/02/2003EP1305317A1 Dihydroporphyrin derivatives and their uses
05/02/2003EP1305316A2 Azabicyclic derivatives and their therapeutic use
05/02/2003EP1305315A2 Polymorphs of zaleplon and methods for the preparation thereof
05/02/2003EP1305314A1 Crystalline therapeutic agent
05/02/2003EP1305294A2 Imidazolyl derivatives
05/02/2003EP1305026A2 Barbituric acid analogs as therapeutic agents
05/02/2003EP1086103B1 Pyrido 2,3-b]indolizine derivatives and aza analogues thereof; crf 1 specific ligands
05/02/2003EP0672047B1 ANTIALLERGIC IMIDAZO[1,2-a]THIENO[ 2,3-d]AZEPINE DERIVATIVES
05/02/2003CA2411009A1 Heterocyclo-alkylsulfonyl pyrazoles
05/01/2003WO2003035644A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003WO2003035553A2 A process for the microbiological decontamination of water by means of photosensitive agents
05/01/2003WO2003035076A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
05/01/2003WO2003035075A1 Inhibitors of human phosphatidyl-inositol 3-kinase delta
05/01/2003WO2003035065A1 Benzimidazoles and analogues and their use as protein kinases inhibitors
05/01/2003WO2003034987A2 Androgen receptor modulators and methods of use thereof
05/01/2003WO2002100828A3 Process for the production of zaleplon
05/01/2003WO2002012442A3 Heterocyclic compounds as ligands of the gabaa receptor
05/01/2003WO2001096318A8 Cyclic urea compounds and preparation thereof
05/01/2003US20030083518 Substituted alcohols useful in treatment of Alzheimer's disease
05/01/2003US20030083494 Porphyrins containing multiple carborane cages which selectively accumulate in neoplastic tissue within the irradiation volume; anticancer agents
05/01/2003US20030083328 Fungicidal triazolopyrimid-7-ylideneamines
05/01/2003US20030083327 Inhibitors of Aurora-2 protein kinases and Glycogen synthase kinase-3 (GSK-3); cancer, diabetes, Alzheimer's disease, and schizophrenia treatment
05/01/2003US20030079311 Suspension bushing, motor vehicle and a suspension cross-member for a motor vehicle
05/01/2003CA2466813A1 Benzimidazole derivatives and their use as kdr protein kinase inhibitors
05/01/2003CA2464632A1 A process for the microbiological decontamination of water by means of photosensitive agents
05/01/2003CA2463975A1 Dihydroxypyrimidine carboxamide inhibitors of hiv integrase
05/01/2003CA2463311A1 Androgen receptor modulators and methods of use thereof
04/2003
04/30/2003CN1414964A Antibacterial heterobicyclic substituted phenyl oxazolidinones
04/30/2003CN1414858A Combinations of receptor tyrosine kinase inhibitor with a1-acidic glycoprotein binding organic compound
04/30/2003CN1414849A Carboxylic acid amides, medicaments containing these compounds and the use and preparation thereof
04/30/2003CN1413990A Epimino substituted benzene derivative
04/30/2003CN1107068C 2-amino-7-(1-substituted-2-hyroxyethyl)-3.5-diphydro-pyrrolo (3,2-D) pyrimidine-4-ones
04/29/2003US6555688 Method for the production of triethylene diamine making use of ethylene diamine
04/29/2003US6555687 Chloropyrimidine intermediates
04/29/2003US6555681 Reducing and cleaving an diammonium salt of a tetraaza-tetracyclic compound using a stoichiometric amount of an alkali boron hydride at a pH of 11 to a tetraaza-bicyclic compound; transition metal complexes as bleach catalysts
04/29/2003US6555567 Substituted spiroheterocyclic 1H-3-aryl-pyrrolidine-2,4-dione derivatives, processes for their preparation, and their use as pesticides
04/29/2003US6555550 Musarinic agonists and antagonists
04/29/2003US6555545 Adenosine, caffeine, and 8-styryl-1,3,7-alkyl xanthine derivatives as wound healing agents
04/29/2003US6555542 Sulfonamide lactam inhibitors of FXa and method
04/29/2003CA2134347C Thiazole or imidazole derivatives as maillard reaction inhibitors
04/24/2003WO2003033500A1 Photoactivable nitrogen bases
04/24/2003WO2003033499A2 Inhibitors of cyclin-dependent kinases, compositions and uses related thereto
04/24/2003WO2003033480A1 Lactam derivatives as antagonists for human 11cby receptors
04/24/2003WO2003033478A1 Alkynylated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitors
04/24/2003WO2003033477A1 Alkynlated fused ring pyrimidine compounds as matrix metalloprotease-13 inhibitor
04/24/2003WO2003033476A1 Pyrimidinones as melanin concentrating hormone receptor 1
04/24/2003WO2003032997A1 Pyrimidine derivatives, pharmaceutical agent containing said compounds, use and method for making same
04/24/2003WO2003032996A1 Imidazo (4,3-e)-1,2,4-triazolo(1,5-c) pyrimidines as adenosine a2a receptor antagonists
04/24/2003WO2003032989A1 1,4-disubstituted benzo-fused urea compounds as cytokine inhibitors
04/24/2003WO2003032911A2 Anti-angiogenic and cytotoxic fused pyrimidines
04/24/2003WO2003032897A2 Azabicyclic compounds for the treatment of fibromyalgia syndrome
04/24/2003WO2003032731A1 Iminobenzoxazines, iminobenzthiazines and iminoquinazolines for controlling invertebrate pests
04/24/2003WO2002058690A3 Methods for the treatment of diseases using malonyl-coa decarbox ylase inhibitors
04/24/2003WO2002057259A3 Pyrazole compounds useful as protein kinase inhibitors
04/24/2003US20030078418 Useful potentiators of beta -lactam antibiotics; therapy
1 ... 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 ... 573